GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Faron Pharmaceuticals Oy (LSE:FARN) » Definitions » 5-Year Yield-on-Cost %

Faron Pharmaceuticals Oy (LSE:FARN) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 11, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Faron Pharmaceuticals Oy 5-Year Yield-on-Cost %?

Faron Pharmaceuticals Oy's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Faron Pharmaceuticals Oy's 5-Year Yield-on-Cost % or its related term are showing as below:



LSE:FARN's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.84
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Faron Pharmaceuticals Oy's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Faron Pharmaceuticals Oy's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Faron Pharmaceuticals Oy's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Faron Pharmaceuticals Oy's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Faron Pharmaceuticals Oy's 5-Year Yield-on-Cost % falls into.



Faron Pharmaceuticals Oy 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Faron Pharmaceuticals Oy is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Faron Pharmaceuticals Oy  (LSE:FARN) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Faron Pharmaceuticals Oy 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Faron Pharmaceuticals Oy's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Faron Pharmaceuticals Oy (LSE:FARN) Business Description

Traded in Other Exchanges
Address
Joukahaisenkatu 6 B, Turku, FIN, 20520
Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company developing novel treatments for medical conditions with unmet needs. The company has a pipeline based on the receptors involved in the regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy in phase I/II development as a novel macrophage checkpoint immunotherapy for patients with untreatable solid tumours, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation. Traumakine, the company's investigational intravenous interferon beta-1a is an anti-viral and anti-inflammatory agent, being tested in several Phase III studies around the world against COVID-19.

Faron Pharmaceuticals Oy (LSE:FARN) Headlines

No Headlines